Your counterfeit seizure is documented to the SKU. Your pipeline is not documented at all.

Your firm finds the factories, the diverted containers, the unauthorized sellers on marketplace platforms. The work is technical, cross-border, and often urgent. Your pipeline, if it is like most in this trade, runs on two feeds: law firm referrals and inbound from brands already in crisis. Both have hard ceilings. The first is capped by the referring firm's own caseload and conflicts. The second is capped by the fact that not every brand in trouble knows you exist until the damage is already public.

Referrals From Counsel Reach Their Limit

Law firms that handle IP litigation, customs seizures, or trade dress disputes are natural partners. They call you when a client needs a factory raid, a supply chain trace, or evidence of counterfeit pharmaceuticals entering the gray market. The relationship is built on trust and mutual discretion. It is also built on finite capacity.

A referring law firm can only send you what its own client base generates. If that firm lands a major pharmaceutical manufacturer, you may see a surge of work. If that firm loses a key partner, or if the partner who liked you retires, the channel thins without warning. The referral pipeline is not something you control. It is something you inherit, and it inherits the limits of someone else's business.

You also compete with other investigators and brand protection agencies for the same law firm attention. Some of those competitors are larger, with broader service menus. Some are cheaper, with thinner operations. The law firm has no obligation to send you everything. You are a vendor in their ecosystem, not a partner in their P&L.

The Inbound Crisis Model Is Unpredictable

The second feed is more dramatic. A brand discovers counterfeit product in its authorized distribution channel. A pharmaceutical company finds faked packaging in a foreign market. A luxury goods house sees its trademark on goods that fail basic safety testing. The brand searches, finds your firm, and calls in a panic.

This work is high-stakes and high-margin. It is also impossible to forecast. You cannot build staffing, technology investment, or geographic expansion around the hope that more brands will have more crises at the right moment. The inbound crisis model rewards visibility, but visibility in this trade is complicated. A brand protection firm that advertises too loudly signals that it lacks the discretion its clients require. The paradox is real: you need to be known, but not known widely.

The Buyers You Need to Reach Are Not Searching

The general counsel at a mid-market medical device company does not wake up thinking about counterfeit risk. The brand protection manager at a consumer electronics firm is busy with authorized retailer compliance and MAP enforcement. The compliance officer at a pharmaceutical distributor is focused on FDA pedigree requirements and DSCSA serialization. Counterfeit risk is on their list, but it is not at the top.

Your job is to reach them before the crisis, not during it. The correspondence must land with a specific, credible proposition that names their actual exposure. For the medical device company, that is the risk of counterfeit components in their contract manufacturing chain. For the consumer electronics firm, it is the revenue leakage from unauthorized sellers undercutting authorized channels on Amazon and Tmall. For the pharmaceutical distributor, it is the liability exposure when counterfeit product enters their supply chain and they cannot prove chain of custody.

These are not generic pain points. They are sector-specific, role-specific, and urgent enough to warrant a conversation. The correspondence must show that you understand the buyer's industry well enough to name the problem without naming their specific situation.

Email Correspondence to Named Roles

ROI Wire builds lists by vertical and role, not by broad industry category. For brand protection, the relevant titles include General Counsel, VP of Brand Protection, Head of Anti-Counterfeiting, Chief Compliance Officer, and in some organizations, the Director of Supply Chain Security or the Head of Trade Compliance. These are not junior roles. They are senior people with limited time and high skepticism.

The Email Correspondence program reaches them with a short, direct message. The subject line is plain, often referencing the specific risk or the firm's own capability. The body states the problem in one sentence, the firm's relevant experience in one sentence, and the request for a brief call in a third. There is no attachment. No brochure. No case study with identifying details.

The follow-up emails, sent at measured intervals, reference the prior message by date. They do not escalate in urgency. They do not offer discounts or limited-time offers. They simply restate the firm's capability in slightly different terms, often with a different angle on the same buyer's risk. The fourth email might mention a specific regulatory development, such as the U.S. Customs and Border Protection's increased scrutiny of e-commerce shipments under the de minimis threshold, and how that affects the buyer's enforcement options. The seventh email might reference a recent enforcement action by the Department of Justice against a counterfeit pharmaceutical network, not to alarm, but to demonstrate that the firm tracks the landscape.

Direct Mail for Sensitive Engagements

Direct Mail serves a particular function in brand protection. A physical letter, sent to the general counsel's office or the brand protection manager's corporate address, signals a level of discretion that email cannot match. The letter is brief, on plain letterhead, and it does not mention the recipient's competitors or any specific incident. It states the firm's focus, names the industries it serves, and proposes a confidential conversation.

The letter often arrives before the email, or simultaneously. The email that follows references the letter by date: "I sent you a note on March 12 regarding..." This creates continuity. The recipient may not remember the letter, but the reference to it implies an ongoing, deliberate effort rather than a mass solicitation.

For pharmaceutical and medical device companies, where regulatory scrutiny is intense and communications are often monitored, the Direct Mail channel is especially important. A letter in a FedEx envelope or a hand-addressed standard envelope passes through different review processes than email. It may reach the recipient when their inbox is filtered by compliance teams. The physical artifact also demonstrates that the sender has invested in the approach, which signals seriousness.

Retargeting Reinforces the Correspondence

Retargeting places digital display and social placements in front of the same named buyer profiles, sequenced to the correspondence program. A general counsel who received the letter and opened the email sees a LinkedIn placement or a display ad that references the same firm name and the same focus. The creative is restrained: no animation, no urgency, no offer. The placement simply reminds the recipient that the firm exists and that it specializes in counterfeit and brand protection.

The retargeting does not replace the letters or emails. It reinforces them. The buyer who ignored the first email may notice the placement, then open the second email with slightly more recognition. The buyer who forwarded the letter to a colleague may see the placement and be reminded to follow up. The channel is a background signal, not a primary push.

Phone Follow-Up References the Prior Contact

The phone call comes after the letter and email have landed. The operator does not introduce the firm from scratch. The opening is specific: "I sent you a note on March 12 about supply chain counterfeit risk for medical device manufacturers. I wanted to follow up briefly." The recipient either remembers the correspondence or they do not. Either way, the call has a context that is not invented.

The operator is trained on the firm's vertical and service parameters. They know the difference between a counterfeit pharmaceutical investigation and a luxury goods gray market trace. They know that the general counsel at a pharmaceutical company is concerned with FDA notification obligations and potential criminal referral, while the brand protection manager at a consumer goods company is concerned with marketplace takedown procedures and civil enforcement. The operator does not read from a generic script. They speak from the correspondence that the buyer has already received.

The call is short. The goal is not to sell the full engagement. The goal is to confirm that the buyer has the problem, or has responsibility for it, and to schedule a deeper conversation with the firm's principal or a senior investigator. The operator books the meeting directly into the client's calendar.

What the Correspondence Actually Says

The content of the correspondence is specific to the vertical. For a pharmaceutical manufacturer, the letter might reference the risks of counterfeit API entering through secondary suppliers, the challenges of DSCSA compliance, and the firm's capability in forensic authentication and supply chain tracing. For a luxury goods house, it might reference the revenue impact of parallel import and the firm's work in marketplace monitoring and physical enforcement coordination.

The correspondence never claims specific results for named clients. It does not say "we recovered $X million for a major pharmaceutical company." It says "we trace counterfeit product to source, coordinate with customs and law enforcement, and document chains of custody for civil or criminal action." The proposition is the work, not the outcome. The outcome is contingent on the client's specific situation, and claiming it in advance would be both inaccurate and indiscreet.

The tone is dry and knowing. It assumes the buyer is sophisticated enough to understand the risk without being alarmed. It does not use words like "protect your brand" or "safeguard your reputation." Those are abstractions. The correspondence names the actual work: factory identification, product authentication, marketplace takedown, customs seizure support, civil litigation evidence, criminal referral coordination.

Revenue Share and Retainer Structures

Engagement structures vary. Some brand protection firms work on a retainer basis, with a monthly fee for ongoing monitoring, investigation, and enforcement support. Others work on a success fee or revenue share, where the firm takes a percentage of recovered damages, seized goods value, or cost avoidance. Some engagements mix both: a retainer for baseline monitoring, with additional fees for major enforcement actions.

Where revenue share genuinely fits the engagement, ROI Wire states the mechanic plainly. The client covers ad spend and infrastructure cost. ROI Wire takes a share of the revenue the program brings in. This aligns the program's incentives with the client's. It also requires that the client have a clear mechanism for attributing revenue to specific leads, which not every firm does.

Where revenue share does not fit, the engagement runs on retainer. The work is the work. The pricing is the pricing. There is no universal model, and ROI Wire does not publish percentages or terms.

ROI Wire Does Not Touch the Investigation Itself

The correspondence program is strictly the outreach. ROI Wire does not conduct investigations, access client data, or participate in enforcement actions. It does not review product samples, analyze supply chain documents, or communicate with law enforcement on the client's behalf. The client firm handles all of that. ROI Wire's role is to start the conversation that leads to the engagement.

This separation matters for confidentiality. The client firm's relationships with its own clients are protected. The correspondence program does not reference those relationships, does not name those clients, and does not claim their results. The buyer who responds to the correspondence is entering a new relationship with the client firm, not becoming part of a public reference list.

Who This Program Is Not For

ROI Wire does not take on brand protection firms that are primarily technology vendors selling software platforms. The correspondence is designed for service firms that do investigative and enforcement work, not for SaaS companies with a brand protection module. The buyer conversation, the proof points, and the sales cycle are different.

ROI Wire also does not take on firms that are unwilling to invest in the program's infrastructure. The list building, the correspondence sequencing, the retargeting setup, and the phone follow-up require client input on service parameters, buyer profiles, and engagement terms. A firm that cannot or will not provide this input will not get good results.

Firms that are combative with their own buyers, that negotiate fees after the work is done, or that lack the operational capacity to handle increased inquiry volume are not a fit. The program generates qualified conversations. It does not fix a broken operation.

The Work Is Precise, and the Copy Is Plain

Brand protection is not a service that benefits from hype. The buyers are general counsel and compliance officers who have seen every kind of vendor pitch. They respond to specificity, discretion, and evidence that the sender understands their actual risk. The correspondence from ROI Wire is written in that register. It names the work plainly. It does not inflate it into "brand integrity solutions" or "intellectual property defense ecosystems."

The plainness is the credibility. A letter that says "we find counterfeit factories and document the supply chain" is more credible than one that says "we empower brands to protect their most valuable assets." The buyer knows the difference. The buyer is the one who has to explain the engagement to their board, their CFO, or their enforcement partners. They need language that holds up under scrutiny.